Some of the proteins that are encapsulated within the lumen, or incorporated on the exosome surface, have been defined as possible biomarkers, such as tetraspanin CD63, Alix, and TSG101, while other proteins can be used to distinguish tumor-derived exosomes from non-tumor-derived ones, such as EGFR, EphA2, and EpCAM [112]. This evidence concerns the gene EPHA2 and neoplasm.